نتائج البحث

First real-world clinical experience with [177Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer beyond VISION and TheraP criteria

• Authors : Ling, Sui wai; de Lussanet de la Sablonière, Quido; Ananta, Michael

Subjects: dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; article; article

• Source: Ling, S W, de Lussanet de la Sablonière, Q, Ananta, M, de Blois, E, Koolen, S L W, Drexhage, R C, Hofland, J, Robbrecht, D G J, van der Veldt, A A M, Verburg, F A & Brabander, T 2025, 'First

تفاصيل العنوان

Quantification of biochemical PSA dynamics after radioligand therapy with [177Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model

• Authors : Siebinga, Hinke; de Wit-van der Veen, Berlinda J.; de Vries-Huizing, Daphne M.V.

Subjects: Lu-PSMA-I&T; NONMEM; PKPD

• Source: EJNMMI physics vol.11 (2024) date: 2024-04-23 nr.1 [ISSN 2197-7364]

تفاصيل العنوان

Estimation of kidney doses from [177Lu]Lu-DOTA-TATE PRRT using single time point post-treatment SPECT/CT.

• Authors : Spink, Safia; Gillett, Daniel; Heard, Sarah

Subjects: Dosimetry; Dota-tate; Lutate

تفاصيل العنوان

Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

• Authors : Schürrle, SB; Eberlein, U; Ansquer, C

Subjects: Journal Article

تفاصيل العنوان

Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics

• Authors : Cheng, Jordan; Zink, Joke; O’Neill, Edward

Subjects: article

• Source: Cheng, J, Zink, J, O’Neill, E, Cornelissen, B, Nonnekens, J, Livieratos, L & Terry, S Y A 2024, 'Enhancing [ 177 Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic

تفاصيل العنوان

The Balance Between the Therapeutic Efficacy and Safety of [177Lu]Lu-NeoB in a Preclinical Prostate Cancer Model

• Authors : Verhoeven, Marjolein; Haeck, Joost; de Blois, Erik

Subjects: dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; article; article

• Source: Verhoeven, M, Haeck, J, de Blois, E, Orlandi, F, Barbato, D, Tedesco, M, Konijnenberg, M & Dalm, S U 2024, 'The Balance Between the Therapeutic Efficacy and Safety of [ 177 Lu]Lu-NeoB in a Preclinical

تفاصيل العنوان

Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis

• Authors : Rubino, M; Di Stasio, G; Bodei, L

Subjects: Paraganglioma; Pheochromocytoma; PRRT

تفاصيل العنوان

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2):an open-label, randomised, phase 3 study

• Authors : Singh, Simron; Halperin, Daniel; Myrehaug, Sten

Subjects: article

• Source: Singh, S, Halperin, D, NETTER-2 Trial Investigators, Myrehaug, S, Herrmann, K, Pavel, M, Kunz, P L, Chasen, B, Tafuto, S, Lastoria, S, Capdevila, J, García-Burillo, A, Yoo, C, Halfdanarson, T R,

تفاصيل العنوان

Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial.

• Authors : Herrmann, Ken; Gafita, Andrei; de Bono, Johann

Subjects: 177Lu-PSMA-617; Nomogram; Overall survival

تفاصيل العنوان

Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer : A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM26

• Authors : Baun, Christina; Olsen, Birgitte Brinkmann; Alves, Carla Maria Lourenco

Subjects: Gastrin-releasing peptide receptor; RM26; Breast cancer

تفاصيل العنوان